Optos plc (LSE: OPTS), a leading medical technology company for the design, development, manufacturing and marketing of retinal imaging devices, today announced that the Company will be presenting at the Goldman Sachs 27th Annual Global Healthcare Conference being held in Dana Point, California, USA.

Who: Stephane Sallmard, Chief Executive Officer

When: Tuesday 13 June 2006, 09h15 PT

Note to Editors

Optos is incorporated in Scotland under the Companies Act 1985 with registered number SC139953 and with its subsidiaries collectively is known as Optos plc. Founded in 1992 Optos plc is a leading medical technology company for the design, development, manufacturing and marketing of devices able to image the retina, the light-sensitive area at the back of the eye. Optos' platform technology is the Panoramic200 Scanning Laser Ophthalmoscope device - known as the P200. In a quarter of a second the P200 device produces a high resolution image of up to 200 degrees or approximately 82 percent of the retina in a single capture. The image - branded the optomap(R) Retinal Exam - provides eye care practitioners with clinically useful information that facilitates the early detection of disorders and diseases evidenced in the retina. Optos believes that its technology provides an unequalled combination of wide-field retinal imaging, speed and convenience for both practitioner and patient. Optos plc is headquartered in Dunfermline, Scotland and currently has approximately 220 employees serving more than 2,250 customers in four country markets - USA, Canada, UK and Germany. To date over 7.5 million optomap(R) Retinal Exams have been conducted. Optos plc trades on the Main Market of the London Stock Exchange under the symbol OPTS.

Source: prnewswire